IGF1 and polycystic ovary syndrome: Moreover, a study demonstrated that the upregulation of lncRNA HCP5 in PCOS patients had a similar effect on IGF1 through the competitive inhibition of miR-27a-3p; thus, it can also be utilized as a therapeutic target [100].